Fundação Butantan
↗São Paulo, Brazil
Fundação Butantan is a private, non-profit organization established in 1984 to support the research, development, teaching, and cultural activities of the Instituto Butantan. It acts as the operational and financial arm of the Institute, allowing for agile management of public funds, capital investments, and partnerships to produce immunobiologicals and biopharmaceuticals.
Instituto Butantan itself is a public institution affiliated with the São Paulo State Secretariat of Health and is one of the world's major scientific centers. It is the largest producer of vaccines and serums in Latin America, supplying a significant portion of the vaccines and 100% of the antivenoms used in Brazil's public health system (SUS).
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Vaccines and Immunobiologicals
SIZE & FINANCIALS
Employees:1001-5000
Founded:1984
Ownership:nonprofit
Status:operating
PIPELINE
Stage:Phase 2
Lead Drug Stage:Commercial (Vaccines)
Modalities:Vaccines, Monoclonal antibodies, Antivenoms
Trial Phases:Phase 2: 1 | Phase 4: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:São Paulo State Secretariat of Health, Brazilian Ministry of Health, World Health Organization (WHO), Pan American Health Organization (PAHO), University of São Paulo, Bill & Melinda Gates Foundation
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Esper Kallas - Director
LINKS
Website:fundacaobutantan.org.br
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Fundação Butantan and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Fundação Butantan. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.